SCHEMBL7275837

SCHEMBL7275837

FC(F)Oc1ccc(C(Cl)c2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
MAPT P10636 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
ALOX15 P16050 2/20 0.44
GAA P10253 1/20 0.42
KMT2A Q03164 7/20 0.41
MEN1 O00255 6/20 0.41
TEAD4 Q15561 1/20 0.41
DAGLA Q9Y4D2 1/20 0.40
TSHR P16473 1/20 0.39
LMNA P02545 5/20 0.39
DRD1 P21728 1/20 0.39
HTT P42858 4/20 0.39
HSP90AA1 P07900 1/20 0.38
PKM P14618 1/20 0.38
HPGD P15428 1/20 0.38
CCR6 P51684 1/20 0.38
ATM Q13315 1/20 0.38
GFER P55789 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033615 0.83 GRM4 (0.44) ALDH1A1MAPTNPC1RAB9AGAA
SCHEMBL7267014 0.80 SRD5A2 (0.47) ALDH1A1MAPTNPC1RAB9AALOX15
SCHEMBL3831819 0.80 ALDH1A1 (0.44) ALDH1A1MAPTNPC1RAB9AALOX15
SCHEMBL23042038 0.80 CNR2 (0.46) ALDH1A1NPC1RAB9AGAAKMT2A
SCHEMBL13653555 0.78 MAPT (0.46) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL153060 0.78 ALDH1A1 (0.50) ALDH1A1MAPTNPC1RAB9AALOX15
SCHEMBL11820501 0.78 TSHR (0.61) ALDH1A1RAB9ATSHRLMNAHPGD
SCHEMBL874908 0.75 ACP3 (0.56) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL151375 0.75 TSHR (0.65) ALDH1A1RAB9ATSHRLMNAHPGD
SCHEMBL11065049 0.75 DRD1 (0.56) ALDH1A1MAPTNPC1RAB9AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-4935414-A New indolylpropanols, processes for their preparation and their use, and preparations containing the compounds BEIERSDORF AG (DE) 1990-06-19 US disclosed
EP-0297380-A2 Indolyl propanols, process for their preparation, their uses and preparation containing them Beiersdorf-Lilly GmbH (DE) 1989-01-04 EP disclosed